DRCMR Logo 300px Color
 

Improving cerebral blood flow and cognition in patients with cerebral small vessel disease. The ETLAS-2 Trial

  • Funded By: Novo Nordisk Fonden |
  • Total Amount (DKK): 5.974.583 |
  • DRCMR Amount (DKK): 2.210.500 |
  • Grant Year: 2020 |
  • Main Grant Holder: Christina Kruuse |
  • DRCMR PI: Esben Thade Petersen |